Results 31 to 40 of about 199,675 (257)

Coronavirus: Penyakit Lama, Virus Lama, Kemasan Baru

open access: yesKELUWIH: Jurnal Kesehatan dan Kedokteran, 2020
Abstract— Covid -19, a virus strain and a member of family with known member as Severe Acute Respiratory Disease (SARS) or Middle East Respiratory Syndrome (MERS), but having a potentially lethal differences in not readily recognized by our immunity.
openaire   +3 more sources

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]

open access: yesInternational Journal of COPD, 2020
Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S. Int J Chron Obstruct Pulmon Dis. 2020;15:745–754. The authors have advised there is an error in Figure 4 on page 751. The Q2 subgroup of the placebo arm has the label of “−0.
Donohue JF   +3 more
doaj  

LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

open access: yesInternational Journal of COPD, 2017
Background Randomized controlled trials (RCTs) indicate that long-acting bronchodilator combinations, such as β2-agonist (LABA)/muscarinic antagonist (LAMA), have favorable efficacy compared with commonly used COPD treatments.
G. Rodrigo   +8 more
semanticscholar   +1 more source

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

open access: yesInternational Journal of COPD, 2020
Wen-Chien Cheng,1– 6 Biing-Ru Wu,1,3,5,6 Wei-Chih Liao,1,2,4,7 Chih-Yu Chen,1 Wei-Chun Chen,1,3– 6 Te-Chun Hsia,1,4,8 Chih-Yen Tu,1– 3 Chia-Hung Chen,1,2,7 Wu-Huei Hsu1 1Division of Pulmonary and Critical Care Medicine, Department of ...
Cheng WC   +8 more
doaj  

Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD

open access: yesInternational Journal of COPD, 2021
Nirupama Putcha,1 Ayca Ozol-Godfrey,2 Shahin Sanjar,2 Sanjay Sharma2 1Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USACorrespondence ...
Putcha N   +3 more
doaj  

Research into the themes covered in Pandita Jamyangarav’s compilation of sources from the time of the Mongol khans

open access: yesНовые исследования Тувы
This article analyzes the content of the work “The Lineage of the Mongol Khans in Mongolian Texts” written in the late 19th / early 20th centuries by Pandita Jamyangarav (1867–1918), a Mongolian monk, poet, philosopher and scholar.
Ганболд Дашлхагваа   +2 more
doaj   +1 more source

Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study

open access: yesJournal of Thoracic Disease, 2020
Background Patients with bronchiectasis are often treated with bronchodilators such as long-acting muscarinic antagonists (LAMA) or long-acting beta-agonists (LABA) for their symptoms, but empirical evidence supporting such practice is sparse.
Su Yeon Lee   +3 more
semanticscholar   +1 more source

Factors influencing pharmacological treatment in COPD: a comparison of 2005 and 2014

open access: yesEuropean Clinical Respiratory Journal, 2017
Introduction: The aim was to investigate how the pattern of pharmacological treatment in Swedish patients with chronic obstructive pulmonary disease (COPD) has changed over a decade, and to identify factors associated with treatment.
Josefin Sundh   +6 more
doaj   +1 more source

Leaving Against Medical Advice Among Patients With Brain Tumours in the Middle East: Khoula Hospital Experience

open access: yesInternational Clinical Neuroscience Journal, 2020
Background: Leaving against medical advice (LAMA) can be defined broadly as a patient’s insistence upon leaving the hospital against the treating team has expressed advice, which is both a challenge and concern for physicians, as these patients lost to ...
Tariq AL-Saadi   +8 more
doaj   +1 more source

Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study

open access: yesInternational Journal of COPD, 2023
Juan José Soler-Cataluña,1– 3 José Luis Izquierdo,4,5 Mónica Juárez Campo,6 Antoni Sicras-Mainar,7 Javier Nuevo6 1Pneumology Department, Hospital Arnau de Vilanova-Lliria, Valencia, Spain; 2Medicine Department, Universitat de València, Valencia, Spain ...
Soler-Cataluña JJ   +4 more
doaj  

Home - About - Disclaimer - Privacy